Michael Mano
Vermögen: 194 460 $ am 31.08.2026
Vermögen: 194 460 $ am 31.08.2026
Michael Mano is Secretary, Chief Legal Officer & Executive VP at Karyopharm Therapeutics, Inc. since 2020.
Mr. Mano is Trustee at XenoTherapeutics, Inc. Formerly, Mr. Mano was Counsel-Business Development at Biogen, Inc. from 2018 to 2020.
Mr. Mano was Senior Counsel at Proskauer Rose LLP from 2013 to 2018.
Education includes undergraduate studies at St. Michael's College and graduate studies at Washington University School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 94 398 ( 0,42 % ) | 194 460 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | General Counsel | 15.12.2020 |
XenoTherapeutics, Inc.
XenoTherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.12.2020 |
Proskauer Rose LLP
Proskauer Rose LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.01.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Proskauer Rose LLP
Proskauer Rose LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
St. Michael's College
St. Michael's College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Washington University School of Law
Washington University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoTherapeutics, Inc.
XenoTherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen